UP-02.212 Evaluation of Serum Total Testosterone in Patients with Clinically Localized Prostate Cancer von Kratzik, C, Womastek, I, Krall, C, Schatzl, G, Bieglmayer, C, Freibauer, C, Lunglmayr, G

Volltext

ARE LOW SERUM TESTOSTERONE LEVELS A TUMOR MARKER FOR PROSTATE CANCER? von Zeitelberger, A, Schatzl, G, Kratzik, C, Lunglmayr, G

Volltext

Molecular markers and their prognostic impact in patients with advanced prostate cancer undergoing intermittent androgen suppression von Augustin, H, Freibauer, C, Bayer, L, Lunglmayr, G, Tschurlovich, F, Kuber, W, Pummer, K

Volltext

MP-22.07 von Lunglmayr, G., Weidlich, B., Kratzik, C.

Volltext

Early diagnosis of prostate cancer: the continuing debate on the impact on mortality von Höltl, Wolfgang, Lunglmayr, Gerhard

Volltext

MP-22.01 von Augustin, H., Freibauer, C., Bayer, L., Lunglmayr, G., Tschurlovich, F., Kuber, W., Pummer, K.

Volltext

MP-22.07: Long-term androgen deprivation and cognitive function in men with prostate cancer von Lunglmayr, G., Weidlich, B., Kratzik, C.

Volltext

Comparison of an LH–RH Analogue (Goeserelin Acetate, ‘Zoladex’) with Combined Androgen Blockade in Advanced Prostate Cancer: Final Survival Results of an International Multicentre... von Tyrrell, C.J., Altwein, J.E., Klippel, F., Jurincic-Winkler, C., Varenhorst, E., Lunglmayr, G., Boccardo, F., Holdaway, I.M., Haefliger, J.-M., Jordaan, J.P.

Volltext

MP-22.01: Molecular changes during intermittent androgen suppression and their prognostic impact in advanced prostate cancer von Augustin, H., Freibauer, C., Bayer, L., Lunglmayr, G., Tschurlovich, F., Kuber, W., Pummer, K.

Volltext

Multicenter randomized trial comparing zoladex with zoladex plus flutamide in the treatment of advanced prostate cancer. Survival update von Tyrrell, C. J., Altwein, J. E., Klippel, F., Varenhorst, E., Lunglmayr, G., Boccardo, F., Holdaway, I. M., Haefliger, J. M., Jordaan, J. P., Sotarauta, M.

Volltext

Efficacy and tolerability of Casodex in patients with advanced prostate cancer. International Casodex Study Group von Lunglmayr, G

Volltext

Efficacy and tolerability of Casodex in patients with advanced prostate cancer von Lunglmayr, G

Volltext

The Prevalence of Lower Urinary Tract Symptoms in Austrian Males and Associations with Sociodemographic Variables von Haidinger, Gerald, Madersbacher, Stephan, Waldhoer, Thomas, Lunglmayr, Gerhard, Vutuc, Christian

Volltext

Pituitary-gonadal feedback in testicular disorders von Lunglmayr, G, Holzner, J H, Breitenecker, G, Spona, J

Volltext

Effect of polyene macrolid compounds on plasma cholesterol and luteinizing hormone in man von Lunglmayr, G, Spona, J

Volltext

In vitro fertilization with spermatozoa from alloplastic spermatocele von Müller-Tyl, Erich, Deutinger, Josef, Reinthaller, Alexander, Fischl, Franz, Riss, Paul, Lunglmayr, Gerhard

Volltext

Hormone profiles, body mass index and aging male symptoms: results of the Androx Vienna Municipality study von Kratzik, CW, Reiter, WJ, Riedl, AM, Lunglmayr, G, Brandstätter, N, Rücklinger, E, Metka, M, Huber, J

Volltext

Bladder hyperthermia in the treatment of vesical papillomatosis von Lunglmayr, G, Czech, K, Zekert, F, Kellner, G

Volltext

Kontraktile Fibroblasten (Myofibroblasten) in der Lamina propria der Hodenkan lchen vom Menschen von B ck, P., Breitenecker, G., Lunglmayr, G.

Volltext

Comparison of an LH-RH analogue (Goeserelin acetate, 'Zoladex') with combined androgen blockade in advanced prostate cancer: final survival results of an international multicentre... von Tyrrell, C J, Altwein, J E, Klippel, F, Jurincic-Winkler, C, Varenhorst, E, Lunglmayr, G, Boccardo, F, Holdaway, I M, Haefliger, J M, Jordaan, J P

Volltext